Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Clinical trial NCT07513181 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07513181
- Sponsor
- Athos Therapeutics Inc
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-12-14
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.